BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 108 filers reported holding BIOSCRIP INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,086,000 | +43.6% | 2,340,700 | +10.5% | 0.06% | +52.8% |
| Q1 2019 | $4,237,000 | -46.7% | 2,118,500 | -4.9% | 0.04% | -49.3% |
| Q4 2018 | $7,956,000 | +16.5% | 2,228,500 | +1.1% | 0.07% | +51.1% |
| Q3 2018 | $6,832,000 | +9.6% | 2,204,000 | +3.6% | 0.05% | +9.3% |
| Q2 2018 | $6,232,000 | +27.0% | 2,127,000 | +6.6% | 0.04% | +26.5% |
| Q1 2018 | $4,908,000 | -7.6% | 1,995,000 | +9.3% | 0.03% | -2.9% |
| Q4 2017 | $5,309,000 | +1003.7% | 1,824,500 | +942.6% | 0.04% | +1066.7% |
| Q3 2017 | $481,000 | +628.8% | 175,000 | +4275.0% | 0.00% | – |
| Q2 2013 | $66,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |